These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26159902)

  • 21. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
    Butkiewicz D; Drosik A; Suwiński R; Krześniak M; Rusin M; Kosarewicz A; Rachtan J; Matuszczyk I; Gawkowska-Suwińska M
    Int J Cancer; 2012 Oct; 131(7):E1100-8. PubMed ID: 22511383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
    Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
    J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine.
    Mlak R; Krawczyk P; Homa-Mlak I; Powrózek T; Ciesielka M; Kozioł P; Milanowski J; Małecka-Massalska T
    Pathol Oncol Res; 2019 Jul; 25(3):1035-1045. PubMed ID: 30066234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA repair gene polymorphisms at XRCC1, XRCC3, XPD, and OGG1 loci in Maharashtrian population of central India.
    Pramanik S; Devi S; Chowdhary S; Surendran ST; Krishnamurthi K; Chakrabarti T
    Chemosphere; 2011 Feb; 82(7):941-6. PubMed ID: 21183201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SNP-SNP interactions between DNA repair genes were associated with breast cancer risk in a Korean population.
    Han W; Kim KY; Yang SJ; Noh DY; Kang D; Kwack K
    Cancer; 2012 Feb; 118(3):594-602. PubMed ID: 21751184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.
    Butkiewicz D; Rusin M; Sikora B; Lach A; Chorąży M
    Mol Biol Rep; 2011 Nov; 38(8):5231-41. PubMed ID: 21188533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
    Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
    J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians.
    Lawania S; Singh N; Behera D; Sharma S
    Biochem Genet; 2018 Aug; 56(4):375-396. PubMed ID: 29516319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.
    Kiyohara C; Yoshimasu K
    Int J Med Sci; 2007 Feb; 4(2):59-71. PubMed ID: 17299578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women.
    Ding P; Yang Y; Cheng L; Zhang X; Cheng L; Li C; Cai J
    PLoS One; 2014; 9(3):e92083. PubMed ID: 24642895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between polymorphisms in genes related to DNA base-excision repair with risk and prognosis of oropharyngeal squamous cell carcinoma.
    Costa EF; Santos ES; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Mariano FV; Coutinho-Camillo CM; Altemani A; Lima CS; Lourenço GJ
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1917-26. PubMed ID: 27372710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
    Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.
    Kim M; Kang HG; Lee SY; Lee HC; Lee EB; Choi YY; Lee WK; Cho S; Jin G; Jheon HS; Son JW; Lee MH; Jung DK; Cha SI; Kim CH; Kang YM; Kam S; Jung TH; Jheon S; Park JY
    Cancer Sci; 2010 Nov; 101(11):2436-42. PubMed ID: 20731661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.
    Yao CY; Huang XE; Li C; Shen HB; Shi MQ; Feng JF; Pan LX; Tang JH
    Asian Pac J Cancer Prev; 2009; 10(5):859-64. PubMed ID: 20104979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Polymorphism of DNA repair genes (XRCC1, XRCC3, XPC, XPD, XPA) in ethnic groups from Republic of Bashkortostan].
    Kochetova OV; Korytina GF; Akhmadishina LZ; Viktorova TV
    Genetika; 2013 Aug; 49(8):1000-7. PubMed ID: 25474887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.